258 related articles for article (PubMed ID: 28438694)
21. PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer.
Duman BB; Sahin B; Acikalin A; Ergin M; Zorludemir S
J BUON; 2013; 18(1):44-50. PubMed ID: 23613387
[TBL] [Abstract][Full Text] [Related]
22. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
[TBL] [Abstract][Full Text] [Related]
23. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin.
Khan FM; Saleh E; Alawadhi H; Harati R; Zimmermann WH; El-Awady R
Cancer Biol Ther; 2018 Jan; 19(1):25-33. PubMed ID: 29244610
[TBL] [Abstract][Full Text] [Related]
25. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer.
Su F; Hu X; Jia W; Gong C; Song E; Hamar P
J Surg Res; 2003 Jul; 113(1):102-8. PubMed ID: 12943817
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma.
Vecanova J; Hodorova I; Mihalik J; Benicky M; Kluchova D; Rybarova S
Bratisl Lek Listy; 2011; 112(2):67-70. PubMed ID: 21456504
[TBL] [Abstract][Full Text] [Related]
27. Current options in treatment of anthracycline-resistant breast cancer.
Kröger N; Achterrath W; Hegewisch-Becker S; Mross K; Zander AR
Cancer Treat Rev; 1999 Oct; 25(5):279-91. PubMed ID: 10544072
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy enhances tumor vascularization via Notch signaling-mediated formation of tumor-derived endothelium in breast cancer.
Zhang P; He D; Chen Z; Pan Q; Du F; Zang X; Wang Y; Tang C; Li H; Lu H; Yao X; Jin J; Ma X
Biochem Pharmacol; 2016 Oct; 118():18-30. PubMed ID: 27520484
[TBL] [Abstract][Full Text] [Related]
29. Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer.
Kollermann J; Kempkensteffen C; Helpap B; Schrader M; Krause H; Muller M; Miller K; Schostak M
BMC Urol; 2006 Jun; 6():15. PubMed ID: 16803634
[TBL] [Abstract][Full Text] [Related]
30. Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells.
Chen WX; Xu LY; Qian Q; He X; Peng WT; Zhu YL; Cheng L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30201690
[TBL] [Abstract][Full Text] [Related]
31. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
32. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
[TBL] [Abstract][Full Text] [Related]
33. GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients.
Zeng J; Wu H; Liu D; Li L; Li J; Wang Q; Ye M; Huang Q; Yu Z; Zhang J
World J Surg Oncol; 2022 Jun; 20(1):212. PubMed ID: 35729577
[TBL] [Abstract][Full Text] [Related]
34. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.
Zhang Y; Qu X; Jing W; Hu X; Yang X; Hou K; Teng Y; Zhang J; Liu Y
Anticancer Drugs; 2009 Mar; 20(3):208-14. PubMed ID: 19396019
[TBL] [Abstract][Full Text] [Related]
35. Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID?
Hodgkinson VC; ELFadl D; Agarwal V; Garimella V; Russell C; Long ED; Fox JN; McManus PL; Mahapatra TK; Kneeshaw PJ; Drew PJ; Lind MJ; Cawkwell L
J Proteomics; 2012 Feb; 75(4):1276-83. PubMed ID: 22115752
[TBL] [Abstract][Full Text] [Related]
36. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
[TBL] [Abstract][Full Text] [Related]
37. Exosomes: A rising star in breast cancer (Review).
Wang L; Wang B; Wen H; Mao J; Ren Y; Yang H
Oncol Rep; 2020 Aug; 44(2):407-423. PubMed ID: 32627021
[TBL] [Abstract][Full Text] [Related]
38. Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy.
Yokomizo A; Yamamoto K; Kinukawa N; Tsunoda T; Koga H; Naito S
Int J Urol; 2007 Jun; 14(6):500-4. PubMed ID: 17593093
[TBL] [Abstract][Full Text] [Related]
39. Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.
Li S; Payne S; Wang F; Claus P; Su Z; Groth J; Geradts J; de Ridder G; Alvarez R; Marcom PK; Pizzo SV; Bachelder RE
Breast Cancer Res; 2015 Jul; 17(1):91. PubMed ID: 26141457
[TBL] [Abstract][Full Text] [Related]
40. The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity.
Zhai L; Li S; Li X; Li H; Gu F; Guo X; Liu F; Zhang X; Fu L
Pathol Res Pract; 2015 Feb; 211(2):130-7. PubMed ID: 25480692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
